Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease

Hypertension

Volumn 65, Issue 1, 2015, Pages 218-224

  Cifuentes, Diana ^a,b   Poittevin, Marine ^a,b   Dere, Ekrem ^c   Broquères You, Dong ^a,b   Bonnin, Philippe ^a,b,d   Benessiano, Joëlle ^e   Pocard, Marc ^b,d   Mariani, Jean ^f   Kubis, Nathalie ^a,b,d   Merkulova Rainon, Tatyana ^a,b   Lévy, Bernard I ^a,b,d  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BICHAT HOSPITAL   (France)

^f CNRS   (France)

Author keywords

Alzheimer Disease; Animal; Hypertension; Models; Nitric oxide

Indexed keywords

AMYLOID; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; PRESENILIN 1; VASCULOTROPIN A; RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CAPILLARY DENSITY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; HYPERTENSION; MEMORY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPLICATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919446397     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04139     Document Type: Article

References (27)

1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimers disease prevalence. Lancet Neurol. 2011;10:819-828.
2. Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88:640-651.
3. Masters CL, Selkoe DJ. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006262.
4. Rosenblum WI. Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult. Neurobiol Aging. 2014;35:969-974.
5. Gorelick PB, Scuteri A, Black SE, et al; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713.
6. Pimentel-Coelho PM, Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimers disease. Eur J Neurosci. 2012;35:1917-1937.
7. Polidori MC, Pientka L, Mecocci P. A review of the major vascular risk factors related to Alzheimers disease. J Alzheimers Dis. 2012;32:521-530.
8. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol. 2012;2012:367516.
9. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007;69:1850-1858.
10. Qiu C. Preventing Alzheimers disease by targeting vascular risk factors: hope and gap. J Alzheimers Dis. 2012;32:721-731.
11. Ashe KH, Zahs KR. Probing the biology of Alzheimers disease in mice. Neuron. 2010;66:631-645.
12. Radde R, Bolmont T, Kaeser SA, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7:940-946.
13. Dere E, Huston JP, De Souza Silva MA. Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Res Brain Res Protoc. 2005;16:10-19.
14. Inzitari M, Pozzi C, Rinaldi LA, Masotti G, Marchionni N, Di Bari M. Cognitive and functional impairment in hypertensive brain microangiopathy. J Neurol Sci. 2007;257:166-173.
15. Gengler S, Hamilton A, Hölscher C. Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimers disease is impaired in old but not young mice. PLoS One. 2010;5:e9764.
16. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734-746.
17. Pause BM, Zlomuzica A, Kinugawa K, Mariani J, Pietrowsky R, Dere E. Perspectives on episodic-like and episodic memory. Front Behav Neurosci. 2013;7:33.
18. Fuster JM. The prefrontal cortex-an update: time is of the essence. Neuron. 2001;30:319-333.
19. Biron KE, Dickstein DL, Gopaul R, Jefferies WA. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimers disease. PLoS One. 2011;6:e23789.
20. Nih LR, Deroide N, Ler-Dan C, Lerouet D, Soustrat M, Levy BI, Silvestre JS, Merkulova-Rainon T, Pocard M, Margaill I, Kubis N. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell coadministration. Eur J Neurosci. 2012;35:1208-1217.
21. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118:968-976.
22. Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens. 2008;21:72-77.
23. Sanada F, Taniyama Y, Azuma J, Iekushi K, Dosaka N, Yokoi T, Koibuchi N, Kusunoki H, Aizawa Y, Morishita R. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension. 2009;53: 77-82.
24. Katusic ZS, Austin SA. Endothelial nitric oxide: protector of a healthy mind. Eur Heart J. 2014;35:888-894.
25. Austin SA, Santhanam AV, Katusic ZS. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res. 2010;107:1498-1502.
26. Wright JW, Harding JW. The brain RAS and Alzheimers disease. Exp Neurol. 2010;223:326-333.
27. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;68(suppl 2):S74-S87.